/
/
GL Biochem Wins Top Peptide Synthesis Solution in Asia 2026 Award

GL Biochem Wins Top Peptide Synthesis Solution in Asia 2026 Award

GL Biochem has won the Top Peptide Synthesis Solution in Asia 2026 award. Discover how GL Group and JIMEIJIAER deliver pure, clinical-grade peptide solutions worldwide.
2026/06/18
Reading volume: 11

News Details

The Asian peptide industry recently announced a major milestone. GL Biochem has officially won the prestigious "Top Peptide Synthesis Solution in Asia 2026" award. This honor was presented by the authoritative international industry media outlet, Life Sciences Review (ISSN 2831-8331).

企业微信截图_17817714473918.png

This recognition rewards GL Biochem's 28 years of technical expertise, strict quality control, and global service capabilities. It also marks a massive breakthrough for Chinese peptide enterprises in the global supply chain, bringing new power to global life science innovation.

The award committee gave special praise to GL Biochem's core ability to turn complex peptide structures into scale-ready, quality-controlled products. They also highlighted the company's value as a single-source peptide raw material partner. GL Biochem excels at making clinical-grade complex sequence peptides and long-chain peptides containing over 50 amino acids. This technical strength perfectly matches the strategic path GL Biochem has carved out since its founding in 1998.

企业微信截图_178177163067.png

1. Building Global Hard Power Over 28 Years

As one of the earliest companies to focus on peptide science in China, Shanghai-headquartered GL Biochem has grown into a global benchmark for large-scale manufacturing. The company's core competitiveness relies on three strong pillars: a full-chain technical catalog, rigid quality control, and a massive global service network.

Complete Technical Chain Coverage

GL Biochem has built an end-to-end technical network that spans initial laboratory R&D, pilot scaling, and commercial mass production. Because we manage every stage, clients do not need to re-verify materials or switch suppliers as their projects advance. This seamless transition slashes research costs and time.

For example, in a recent antiviral research project, the company successfully synthesized a complex peptide with 58 amino acids and multiple structural modifications. The final product achieved an ultra-high purity level of 98.8%. This material directly helped the client screen potential drug candidates, proving GL Biochem's clinical-grade manufacturing power.

Zero-Defect Quality Control

GL Biochem utilizes a strict three-level quality control system. Every single product batch must pass more than 10 separate verification checks alongside a two-person data audit. Thanks to these high standards, the company has maintained a proud record of zero major quality incidents across 28 years of operations.

Furthermore, our facilities operate in strict compliance with ISO 9001 and GMP standards. We also align our processes with FDA Q7 and EMA ICH Q10 guidelines to provide global pharmaceutical firms with stable, fully compliant raw materials.

Leading Production Scale and Speed

The company operates over 1 million square feet of standardized manufacturing facilities and a 100,000-square-foot R&D center. These spaces feature advanced analytical equipment, including Nuclear Magnetic Resonance (NMR) spectrometers and UPLC-MS platforms. This machinery allows our teams to produce over 10,000 purified custom peptide sequences every month.

By running an integrated supply chain, GL Biochem offers product pricing that is 15% to 20% lower than international competitors. Additionally, we deliver standard sequence peptides rapidly in just 3 to 5 days, while keeping 20% of our production capacity open to handle urgent, highly complex requests.

企业微信截图_17817717004452.png

2. Driving Innovation and Environmental Responsibility

Winning this award is a fresh starting point for GL Biochem as it continues to push the peptide industry forward. On the innovation front, our core R&D team brings an average of over 15 years of industry experience. The company holds more than 200 peptide-related patents and has led over 10 national and municipal research projects. Notably, GL Biochem provided critical technical support for the development of new therapies during global anti-viral crises. Because of these scientific achievements, the company has won official recognition as a national-level "Little Giant" enterprise and a manufacturing champion in Shanghai.

At the same time, GL Biochem practices clean, green manufacturing to balance industrial growth with environmental protection. Our green factories reuse 80% of production wastewater and recycle over 90% of chemical solvents.

Today, GL Biochem serves clients across more than 50 countries and regions. Our work empowers over 100 pharmaceutical firms, biotech companies, and diagnostic developers. Our high-purity peptide products are critical components in drug discovery, gene editing, cell therapy, and vaccine design.

As CEO Dr. Xu Hongyan states:

"Our mission is to drive the industrial scale of peptide technology. Through highly efficient, green, and large-scale manufacturing, we empower global life science innovation."

企业微信截图_1781771743547.png

3. JIMEIJIAER: Bringing Pharmaceutical Purity to Global Cosmetics

At JIMEIJIAER, the premium cosmetic peptide brand of the GL Group, we translate this exact award-winning scientific heritage directly into premium beauty products. Many retail skincare brands struggle to find reliable manufacturing partners because standard cosmetic factories simply lack the advanced synthesis tools needed to keep delicate peptide molecules stable.

We solve this problem completely by utilizing GL Group's 28 years of pure chemical synthesis experience and its extensive portfolio of over 70 cosmetic-related invention patents. JIMEIJIAER specializes in turning high-level scientific concepts into retail-ready anti-aging skincare solutions.

Our premier product line, including the Multi-Peptide Anti-Wrinkle Perfecting Essence, features pure Acetyl Hexapeptide-8 and Decapeptide-4 created inside our state-of-the-art facilities. To protect these delicate ingredients from breaking down in liquid formulas over time, we use Advanced Lyophilization (Freeze-Drying) Technology.

We snap-freeze our precise peptide matrices at -40°C to create our signature Unit-Dose Lyophilized Powder. This dry process locks in 100% biological activity without needing harsh chemical preservatives. In our corporate B2B client case studies, brands using our freeze-dried systems reported a visible reduction in wrinkles among their consumers within just two weeks, proving that pharmaceutical-grade synthesis delivers real retail success.

4. Partner with an Industry Leader Today

GL Biochem acts as a critical upstream component supplier and a trusted CRO/CDMO partner for global drug development and premium cosmetic formulation. We continue to place technical innovation and strict compliance at the center of everything we build.

Explore our full technical capabilities, explore our massive product catalog, or contact our international trade teams by visiting our official digital portal at glanti-wrinklepep.com or utilizing our official corporate contact data:

  • Corporate Address: 519 Ziyue Road, Minhang District, Shanghai, China
  • Mobile Phone Support: +86-13764617728
  • Direct Office Telephone: +8621-61263333
  • Official Business Email: Wuyilin@glschina.com

FAQ

What makes GL Biochem's peptide synthesis solutions award-winning?

GL Biochem won the "Top Peptide Synthesis Solution in Asia 2026" award because of its ability to scale complex peptide sequences, its strict GMP/ISO quality controls, and its 28-year history of zero major quality incidents. Our massive manufacturing scale allows us to deliver high-purity peptides quickly and affordably.

Can JIMEIJIAER handle full-service private label manufacturing for international cosmetic brands?

Yes, absolutely. Leveraging GL Group's 8 global production bases and 3 R&D centers, JIMEIJIAER operates as a complete Contract Development and Manufacturing Organization (CDMO). We manage the entire lifecycle of your cosmetics brand—from custom raw material synthesis and formula stabilization to custom packaging design and automated GMP filling.

Why is freeze-dried peptide technology better for anti-aging skincare products?

Delicate peptide chains can slowly degrade and lose their cell-signaling strength when left in liquid formulas for months on store shelves. JIMEIJIAER’s freeze-drying method removes all moisture to keep the active ingredients completely stable in a dry state, ensuring full laboratory strength the exact moment your customer opens and activates the product.

Share to:
facebook
line
Whatsapp
Pinterest
Tumblr
Linkedin
GL Biochem Helps Create New Peptide Cancer Drug
How GL Group and JIMEIJIAER Power Global Life Science Research